Analysis of Treatment Effectiveness in Longitudinal Observational Data
- 31 August 2007
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 17 (5) , 809-826
- https://doi.org/10.1080/10543400701513967
Abstract
Assessing treatment effectiveness in longitudinal observational data is complicated as patients may change medications at any time. To illustrate, three general statistical strategies were utilized to assess treatment effectiveness in an observational schizophrenia study: ignoring, eliminating, and modeling the switching. Differential switching rates produced dramatic differences in estimates of treatment effectiveness across the strategies, with p-values ranging from nearly 0 to almost 1. Ignoring the treatment switching by utilizing intent-to-treat approaches resulted in treatment effect estimates of near zero. Various methods of eliminating the switching, such as epoch analyses and on-drug subset analyses, along with use of marginal structural models generated reasonably consistent non-zero treatment effect estimates. When analyzing longitudinal observational data, researchers must understand the options, key concepts and assumptions behind the various statistical methods available. Marginal structural models are a promising approach to estimation of causal treatment effects in such data.Keywords
This publication has 30 references indexed in Scilit:
- Methodological Aspects in the Assessment of Treatment Effects in Observational Health Outcomes StudiesApplied Health Economics and Health Policy, 2006
- Doubly Robust Estimation in Missing Data and Causal Inference ModelsBiometrics, 2005
- Marginal Structural Models for Estimating the Effect of Highly Active Antiretroviral Therapy Initiation on CD4 Cell CountAmerican Journal of Epidemiology, 2005
- Marginal Structural Models for Analyzing Causal Effects of Time-dependent Treatments: An Application in Perinatal EpidemiologyAmerican Journal of Epidemiology, 2004
- Effect of Highly Active Antiretroviral Therapy on Time to Acquired Immunodeficiency Syndrome or Death using Marginal Structural ModelsAmerican Journal of Epidemiology, 2003
- Estimating a treatment effect in survival studies in which patients switch treatmentStatistics in Medicine, 2002
- Methods for Claims-Based Pharmacoeconomic Studies in PsychosisPharmacoEconomics, 2002
- Bias and causal associations in observational researchThe Lancet, 2002
- Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research DesignsNew England Journal of Medicine, 2000
- A Comparison of Observational Studies and Randomized, Controlled TrialsNew England Journal of Medicine, 2000